Emergency Department, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):469-477. doi: 10.1016/j.hbpd.2021.07.002. Epub 2021 Jul 24.
Liver injury is one of the most common complications during sepsis. Macrophage migration inhibitory factor (MIF) is an important proinflammatory cytokine. This study explored the role of MIF in the lipopolysaccharide (LPS)-induced liver injury through genetically manipulated mouse strains.
The model of LPS-induced liver injury was established in wild-type and Mif-knockout C57/BL6 mice. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBil) were detected, and the expressions of MIF, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were measured. Liver histopathology was conducted to assess liver injury. Moreover, the inhibitions of MIF with (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) and 4-iodo-6-phenylpyrimidine (4-IPP) were used to evaluate their therapeutic potential of liver injury.
Compared with wild-type mice, the liver function indices and inflammation factors presented no significant difference in the Mif mice. After 72 h of the LPS-induced liver injury, serum levels of ALT, AST, and TBil as well as TNF-α and IL-1β were significantly increased, but the knockout of Mif attenuated liver injury and inflammatory response. In liver tissue, mRNA levels of TNF-α, IL-1β and NF-κB p65 were remarkably elevated in LPS-induced liver injury, while the knockout of Mif reduced these levels. Moreover, in LPS-induced liver injury, the inhibitions of MIF with ISO-1 and 4-IPP alleviated liver injury and slightly attenuated inflammatory response. Importantly, compared to mice with LPS-induced liver injury, Mif knockout or MIF inhibitions significantly prolonged the survival of the mice.
In LPS-induced liver injury, the knockout of Mif or MIF inhibitions alleviated liver injury and slightly attenuated inflammatory response, thereby prolonged the survival of the mice. Targeting MIF may be an important strategy to protect the liver from injury during sepsis.
肝损伤是脓毒症最常见的并发症之一。巨噬细胞移动抑制因子(MIF)是一种重要的促炎细胞因子。本研究通过基因敲除小鼠模型探讨了 MIF 在脂多糖(LPS)诱导的肝损伤中的作用。
建立野生型和 Mif 敲除 C57/BL6 小鼠 LPS 诱导的肝损伤模型。检测血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和总胆红素(TBil)水平,检测 MIF、肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)的表达。行肝组织病理学检查评估肝损伤程度。此外,采用(S,R)-3-(4-羟苯基)-4,5-二氢-5-异恶唑乙酸甲酯(ISO-1)和 4-碘-6-苯基嘧啶(4-IPP)抑制 MIF,评估其对肝损伤的治疗潜力。
与野生型小鼠相比,Mif 敲除小鼠的肝功能指标和炎症因子无显著差异。LPS 诱导肝损伤 72 h 后,血清 ALT、AST、TBil 及 TNF-α、IL-1β水平显著升高,但 Mif 敲除可减轻肝损伤和炎症反应。在肝组织中,LPS 诱导肝损伤时 TNF-α、IL-1β和 NF-κB p65 的 mRNA 水平明显升高,而 Mif 敲除可降低这些水平。此外,在 LPS 诱导的肝损伤中,MIF 抑制物 ISO-1 和 4-IPP 可减轻肝损伤并轻度减轻炎症反应。重要的是,与 LPS 诱导的肝损伤小鼠相比,Mif 敲除或 MIF 抑制物可显著延长小鼠的生存时间。
在 LPS 诱导的肝损伤中,Mif 敲除或 MIF 抑制物可减轻肝损伤并轻度减轻炎症反应,从而延长小鼠的生存时间。靶向 MIF 可能是保护脓毒症患者肝脏免受损伤的重要策略。